Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vericel Corp (NASDAQ:VCEL)

2.65
Delayed Data
As of 2:16pm ET
 +0.15 / +6.00%
Today’s Change
1.76
Today|||52-Week Range
6.69
-11.67%
Year-to-Date
No recent news for Vericel Corp.

Today’s Trading

Previous close2.50
Today’s open2.50
Day’s range2.25 - 2.65
Volume933,431
Average volume (3 months)1,335,013
Market cap$79.8M
Dividend yield--
Data as of 2:16pm ET, 01/24/2017

Growth & Valuation

Earnings growth (last year)+56.50%
Earnings growth (this year)+2.75%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+77.69%
P/E ratioNM
Price/Sales1.20
Price/Book--

Competitors

 Today’s
change
Today’s
% change
GTXIGTX Inc+0.16+3.18%
TTNPTitan Pharmaceutical...+0.05+1.22%
SPHSSophiris Bio Inc-0.05-1.72%
SBBPStrongbridge Biophar...-0.05-2.08%
Data as of 2:28pm ET, 01/24/2017

Financials

Next reporting dateMarch 13, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$51.2M
Annual profit (last year)-$16.3M
Net profit margin-31.93%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Dominick C. Colangelo
Chief Operating Officer
Daniel R. Orlando
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs